Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of treating cancer sensitive to anti-EGFR therapy and modifying treatment using peroxiredoxin 6 biomarker

US Patent 9588122 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →